A critical discovery in cancer study is arising with the use of VHH fragments to re-engage damaged p53. This essential cancer protector protein is frequently inactivated in various types of tumors, leading uncontrolled https://e-bookmarks.com/story7741419/mini-antibodies-revive-tumor-suppressor-p53-the-new-approach-for-cancer-management